|
Contact: cfeheley@acc.org;
800-253-4636; 301-581-3425
June 7, 2005
Multisequential
MRI Approach Improves Heart Inflammation Diagnosis
Potentially
life-threatening myocarditis attacks can be difficult to identify
with current methods
(BETHESDA, MD)A multisequential approach to cardiovascular
magnetic resonance scans that highlight different aspects of
heart structure and function may offer a better and safer way
to identify potentially deadly inflammation of the heart muscle,
according to a new study in the June 7, 2005, issue of the Journal
of the American College of Cardiology.
“In
our opinion, a comprehensive approach increases the ability
of cardiovascular magnetic resonance scanning to detect myocarditis.
The method also offers the possibility of differentiating
reversible and irreversible myocardial injury,” said
Jeanette Schulz-Menger, M.D., at the Franz-Volhard-Klinik,
Charité Campus Buch, Universität Medizin Berlin
in Germany.
Acute
myocarditis is a sudden, and potentially life-threatening,
inflammation of the heart muscle that can be caused by an
infection, toxins, autoimmune disorders or other causes. It
can be difficult to diagnose because the early symptoms may
look like a case of flu, heart failure or other ailments.
The conventional diagnostic approach involves taking a biopsy
of heart tissue for examination, but even this invasive technique
is not foolproof. Because of the patchy nature of many cases,
some areas of the heart are severely damaged, while others
areas are not affected.
A
reliable imaging technique could help identify patients with
acute myocarditis more quickly and spare them from an invasive
biopsy procedure. The researchers, including lead author Hassan
Abdel-Aty, M.D., used a combination of different magnetic
resonance imaging (MRI) techniques on 25 patients with suspected
acute myocarditis (18 men and seven women) and 23 healthy
controls (13 men and 10 women).
The
so-called T1 and T2 magnetic resonance techniques are somewhat
like taking photographs through a polarizing filter, aligned
vertically for one image and then horizontally for the other.
The researchers also captured images after injecting a contrast
agent called gadolinium-DTPA.
They
found that the combination of techniques produced better results
than any single method.
“The
best diagnostic performance was obtained when any two of the
three sequences were positive in the same patient,”
the researchers wrote.
“Our
recommendation for clinicians is that in patients with suspected
acute myocarditis apply cardiovascular magnetic resonance
when it is available in a center with experience. However,
there is still a need for multicenter prospective trials,”
Dr. Schulz-Menger said.
In
an editorial in the journal, Peter
P. Liu, M.D., F.A.C.C., at the University of Toronto in Ontario,
Canada, and his co-authors noted that this trial compared
the patients with suspected myocarditis to healthy control
subjects. They wrote that future trials should include patients
with conditions that can appear to be myocarditis, in order
to mimic the difficult real-world conditions often faced by
clinicians. Nevertheless, they wrote that they are optimistic
that cardiovascular magnetic resonance will provide invaluable
insights into myocarditis.
Dudley
Pennell, M.D., F.A.C.C., at the Royal Brompton Hospital in
London, who was not connected with this study, said it is
a comprehensive report that gives a fuller picture than earlier
studies.
“It
gives some insight into which of the techniques is better.
One group may say do the T-2, and another group says do the
late-gadolinium; this is the first paper that has directly
compared them, so it gives us useful information in sorting
out what we should be doing in clinical practice,” Dr.
Pennell said.
He
added that he thinks the results of this study will encourage
more institutions to use cardiovascular magnetic resonance
imaging to investigate suspected cases of myocarditis.
The
American College of Cardiology, a 31,000-member nonprofit
professional medical society and teaching institution, is
dedicated to fostering optimal cardiovascular care and disease
prevention through professional education, promotion of research,
leadership in the development of standards and guidelines,
and the formulation of health care policy.
The
American College of Cardiology (ACC) provides these new reports
of clinical studies published in the Journal of the American
College of Cardiology as a service to physicians, the media,
the public, and other interested parties. However, statements
or opinions expressed in these reports reflect the view of
the author(s) and do not represent official policy of the
ACC unless stated so. |